Impact News +++ Rocket Lab keeps winning launch deals, putting its stock on track for this milestone (MarketWatch) +++ ROCKET LAB Aktie -3,36%

HEMOGENYX Aktie

>HEMOGENYX Performance

1 Woche: +6,8%

1 Monat: +39,2%

3 Monate: +613,6%

6 Monate: +655,3%

1 Jahr: 0%

laufendes Jahr: 0%

>HEMOGENYX Aktie

Name:

HEMOGENYX PHARMACEUTICALS PLC

Land:

Großbritannien

Sektor:

Gesundheit

ISIN/ Wkn:

GB00BQVXM815 / A40WGA

Symbol/ Ticker:

5HU0 (Frankfurt)

Kürzel:

FRA:5HU0, ETR:5HU0, 5HU0:GR

Index:

Webseite:

https://hemogenyx.com/

Profil:

Hemogenyx Pharmaceuticals Plc, a clinical-stage bi..
>Volltext..

Marktkapitalisierung:

76.84 Mio. EUR

Unternehmenswert:

79.1 Mio. EUR

Umsatz:

EBITDA:

-5.51 Mio. EUR

Nettogewinn:

-9.28 Mio. EUR

Gewinn je Aktie:

-2.63 EUR

Schulden:

2.62 Mio. EUR

Liquide Mittel:

0.27 Mio. EUR

Operativer Cashflow:

-6.62 Mio. EUR

Bargeldquote:

0.17

Umsatzwachstum:

Gewinnwachstum:

-48.8%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

HEMOGENYX

Letzte Datenerhebung:

10.10.25

>HEMOGENYX Kennzahlen

Aktien/ Unternehmen:

Aktien: 5.36 Mio. St.

Frei handelbar: 80.07%

Leerverk. Aktien: -

Rückkaufquote: -3.98%

Mitarbeiter: 22

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Neutral

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: -

PEG-Ratio: -0.16

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -169.47%

Eigenkaprendite: -609.3%

>HEMOGENYX Peer Group

Es sind 80 Aktien bekannt.

>HEMOGENYX Chart & Kurs - Stuttgart

>HEMOGENYX News

06.10.25 - 08:06	Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment (Accesswire)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2......

30.09.25 - 15:18	EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx (Alliance)
	The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by...

30.09.25 - 08:06	Hemogenyx Pharmaceuticals PLC Announces Half-year Report (Accesswire)
	Interim Results for the period ended 30 June 2025 LONDON, UK / ACCESS Newswire / September 30, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing therapies desi......

23.09.25 - 17:18	Hemogenyx says exploring commercialisation of treatment for leukaemia (Alliance)
	Hemogenyx Pharmaceuticals PLC on Tuesday said it is has signed a letter of intent with Cellin Technologies OU, a Tallinn...

23.09.25 - 08:48	Hemogenyx signs LOI to explore CAR-T therapy commercialization in Estonia (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.09.25 - 08:06	Hemogenyx Pharmaceuticals PLC Signs Letter of Intent (Accesswire)
	Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in EstoniaFirst Potential Near-Term Revenue Opportunity LONDON / ACCE......

17.09.25 - 08:06	Hemogenyx Pharmaceuticals PLC Announces Third Patient Safety (Accesswire)
	Third Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / September 17, 2025 / Hemogenyx Pharmaceuticals plc is pleas......

11.09.25 - 09:06	Hemogenyx Pharmaceuticals PLC Announces Invitation to Participate at DCNY Summit (Accesswire)
	Hemogenyx Pharmaceuticals Invited to Participate at DCNY Summit LONDON, UK / ACCESS Newswire / September 11, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), is pleased to announce that the Company......

08.09.25 - 18:12	Hemogenyx inks manufacturing partnership deal with Made Scientific (Alliance)
	Hemogenyx Pharmaceuticals PLC on Monday said it has agreed a manufacturing partnership with US-based cell therapy contract...

08.09.25 - 15:15	Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia (PR Newswire)
	PRINCETON, N.J. and NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Hemogenyx Pharmaceuticals plc (LSE: HEMO), a clinical-stage biopharmaceutical company developing targeted......

08.09.25 - 08:06	Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific (Accesswire)
	Hemogenyx Pharmaceuticals Announces Manufacturing Partnership with Made Scientific to Advance HG-CT-1 CAR-T Therapy CITY OF LONDON, GB / ACCESS Newswire / September 8, 2025 / Hemogenyx Pharmaceutic......

05.09.25 - 08:18	Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity (Accesswire)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2......

03.09.25 - 15:31	Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity (Accesswire)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2......

02.09.25 - 10:06	Hemogenyx Pharmaceuticals to issue convertible loan notes (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

01.09.25 - 16:42	Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes (Accesswire)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2......

29.08.25 - 08:06	Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender (Accesswire)
	LONDON, UK / ACCESS Newswire / August 29, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), is pleased to announce that following the conclusion of the formal tender process for the role of statuto......

26.08.25 - 15:06	Hemogenyx stock rises on PS570,000 fundraise for Chimeric trials (Alliance)
	Hemogenyx Pharmaceuticals PLC on Tuesday said it has raised funds to continue phase 1 clinical trials, through an off-market...

26.08.25 - 13:54	Hemogenyx Pharmaceuticals PLC: Hemogenyx raises £570,000 and Director′s Dealing (Accesswire)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2......

15.08.25 - 08:06	Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy (Accesswire)
	Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Third Patient Treated with HG-CT-1 CAR-T Therapy and Completion of First Adult Dose Cohort LONDON, UNITED KINGDOM / ACCESS......

29.07.25 - 09:06	Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director′s Dealing (Accesswire)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Nur der Apathische fühlt sich in seiner Depression wohl. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram